Drugs / [11C]MODAG-005
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07640542 | Jun 2026 → Jul 2027 expected | Parkinson disease, multiple system atrophy | MODAG GmbH | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [11C]MODAG-005 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07640542 ↗ |
| Modality | Diagnostic / imaging agent | “an investigational positron emission tomography/computed tomography (PET/CT) radioligand intended to image pathological alpha-synuclein deposition in the brain” NCT07640542 ↗ |